LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.71 | 17.25 | 18 | 6184 | 0.0029 | 0.0050 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.71 | 17.25 | 6826 | 6184 | 1.1038 | 1.0234 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.71 | 17.25 | 3 | 6184 | 0.0005 | -0.1863 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.71 | 17.25 | 6902 | 6184 | 1.1161 | 1.0261 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.71 | 17.25 | 377 | 6184 | 0.0610 | 0.4383 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 92.71 | 17.25 | 6991 | 6184 | 1.1305 | 1.0291 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 17.25 | 2 | 6239 | 0.0003 | -0.2240 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 17.25 | 6954 | 6239 | 1.1146 | 1.0257 | MN20160310_N02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 17.25 | 7107 | 6239 | 1.1391 | 1.0309 | MN20160310_N02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 17.25 | 177 | 6239 | 0.0284 | 0.3152 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 94.68 | 17.25 | 7100 | 6239 | 1.1380 | 1.0306 | MN20160310_N02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.06 | 17.25 | 400 | 143 | 2.7930 | 1.7998 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 3.06 | 17.25 | 376 | 143 | 2.6254 | 1.7436 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.03 | 17.25 | 668 | 273 | 2.4437 | 1.5026 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 5.03 | 17.25 | 720 | 273 | 2.6339 | 1.5501 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.01 | 17.25 | 805 | 389 | 2.0668 | 1.3504 | MN20160310_N02 | L07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.01 | 17.25 | 1 | 389 | 0.0026 | -0.4692 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 7.01 | 17.25 | 824 | 389 | 2.1155 | 1.3626 | MN20160310_N02 | L09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 8.98 | 17.25 | 1 | 445 | 0.0022 | -0.4552 | MN20160310_N02 | L07 |